Starting in the last century, the ability of physicians to provide effective care progressed immensely and accordingly an increasing number of specialities evolved out of the overarching entity ‘internal medicine’.

Read full article (European Heart Journal (2025) 00, 1–4) here!
 

Despite advances in research and patient management, atherosclerosis and its dreaded acute and chronic sequelae continue to account for one out of three deaths globally. A more individualized approach to patients with ACS is advocated...

Read full article (European Heart Journal (2025) 00, 1–24) here!

In prospectively recruited patients with ACS, initial BT shows a U- shaped relationship with 1- year MACE risk among those with NSTE- ACS, but not in those with STEMI. 

Read full article (Eur J Clin Invest. 2024 Dec;54(12):e14314) here!

Cardiovascular diseases remain the leading cause of global morbidity and mortality. The paper reviews the role of ML in advancing cardiovascular risk assessment and discuss its potential to identify novel therapeutic targets and to improve prevention strategies. 

Read full article (Eur J Clin Invest. 2025;55(Suppl. 1):e70017) here!

Continuously improving cancer-specific survival puts a growing proportion of cancer patients at risk of major adverse cardiovascular events (MACE). Traditional cardiovascular risk factors and selected cancer types were linked to higher MACE risk. 

Read full article ( J Thromb Haemost. 2024 Nov;22(11):3125-3136) here!

An international consortium, including Dr. Florian A. Wenzl from the CMC, has published new insights in The Lancet Respiratory Medicine on optimising trial design for the personalised management of cardiogenic shock. 

Learn more about this Position Paper (Lancet Respir Med. 2025 May 5) here!

Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated individuals. 

Read full article (EurHeartJ (2025) 00, 1–11)

Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine health span and lifespan. The circulatory system not only supplies nutrients and oxygen to all tissues of the human body and removes by-products but also builds the largest interorgan communication network...

Read full article (Nat Rev Cardiol (2025)) 

Artificial intelligence (AI) is set to revolutionize cardiology, offering transformative advancements in diagnosis, treatment, and patient outcomes. However, the integration of AI into clinical practice must be approached with precision and caution... 

Read full article (European Heart Journal (2025) 46, 677–679) 

At the beginning of a new year, we are full of expectations, hopes, and wishes, but also concerns and worries. This ambivalence may be appropriate for the world at large, but I would argue that the European Society of Cardiology (ESC) and its members have already embraced 2025 with enthusiasm and determination. Here are the key reasons.

Read full article (European Heart Journal (2025) 00, 1–3)